Literature DB >> 12819022

The clinical significance of cathepsin S expression in human astrocytomas.

Thomas Flannery1, David Gibson, Menakshi Mirakhur, Stephen McQuaid, Caroline Greenan, Anne Trimble, Brian Walker, Derek McCormick, Patrick G Johnston.   

Abstract

Early local invasion by astrocytoma cells results in tumor recurrence even after apparent total surgical resection, leading to the poor prognosis associated with malignant astrocytomas. Proteolytic enzymes have been implicated in facilitating tumor cell invasion and the current study was designed to characterize the expression of the cysteine proteinase cathepsin S (CatS) in astrocytomas and examine its potential role in invasion. Immunohistochemical analysis of biopsies demonstrated that CatS was expressed in astrocytoma cells but absent from normal astrocytes, oligodendrocytes, neurones and endothelial cells. Microglial cells and macrophages were also positive. Assays of specific activity in 59 astrocytoma biopsies confirmed CatS expression and in addition demonstrated that the highest levels of activity were expressed in grade IV tumors. CatS activity was also present in astrocytoma cells in vitro and the extracellular levels of activity were highest in cultures derived from grade IV tumors. In vitro invasion assays were carried out using the U251MG cell line and the invasion rate was reduced by up to 61% in the presence of the selective CatS inhibitor 4-Morpholineurea-Leu-HomoPhe-vinylsulphone. We conclude that CatS expression is up-regulated in astrocytoma cells and provide evidence for a potential role for CatS in invasion.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12819022      PMCID: PMC1868175          DOI: 10.1016/S0002-9440(10)63641-3

Source DB:  PubMed          Journal:  Am J Pathol        ISSN: 0002-9440            Impact factor:   4.307


  43 in total

1.  Establishment and characterisation of a human glioma cell line.

Authors:  C Chauzy; B Delpech; A Olivier; C Bastard; N Girard; M N Courel; C Maingonnat; T Frébourg; J Tayot; P Creissard
Journal:  Eur J Cancer       Date:  1992       Impact factor: 9.162

2.  Isolation and characterization of human malignant glioma cells from histologically normal brain.

Authors:  D L Silbergeld; M R Chicoine
Journal:  J Neurosurg       Date:  1997-03       Impact factor: 5.115

3.  Ceramide-enhanced urokinase-type plasminogen activator (uPA) release is mediated by protein kinase C in cultured microglia.

Authors:  K Nakajima; S Honda; Y Tohyama; T Kurihara; S Kohsaka
Journal:  Glia       Date:  2000-12       Impact factor: 7.452

4.  In situ detection of mycoplasma contamination in cell cultures by fluorescent Hoechst 33258 stain.

Authors:  T R Chen
Journal:  Exp Cell Res       Date:  1977-02       Impact factor: 3.905

5.  Immunohistochemical and clinical evaluation of cathepsin expression in soft tissue sarcomas.

Authors:  P Würl; H Taubert; A Meye; T Dansranjavin; E Weber; D Günther; D Berger; H Schmidt; H Dralle; F W Rath
Journal:  Virchows Arch       Date:  1997-03       Impact factor: 4.064

Review 6.  Proteases and their inhibitors in human brain tumours: a review.

Authors:  H K Rooprai; D McCormick
Journal:  Anticancer Res       Date:  1997 Nov-Dec       Impact factor: 2.480

7.  Functional expression of human cathepsin S in Saccharomyces cerevisiae. Purification and characterization of the recombinant enzyme.

Authors:  D Brömme; P R Bonneau; P Lachance; B Wiederanders; H Kirschke; C Peters; D Y Thomas; A C Storer; T Vernet
Journal:  J Biol Chem       Date:  1993-03-05       Impact factor: 5.157

8.  Differential distribution of messenger RNAs for cathepsins B, L and S in adult rat brain: an in situ hybridization study.

Authors:  S Petanceska; S Burke; S J Watson; L Devi
Journal:  Neuroscience       Date:  1994-04       Impact factor: 3.590

9.  Interrelationship between differentiation and malignancy-associated properties in glioma.

Authors:  M C Frame; R I Freshney; P F Vaughan; D I Graham; R Shaw
Journal:  Br J Cancer       Date:  1984-03       Impact factor: 7.640

10.  Urokinase and macrophages in tumour angiogenesis.

Authors:  R Hildenbrand; I Dilger; A Hörlin; H J Stutte
Journal:  Br J Cancer       Date:  1995-10       Impact factor: 7.640

View more
  28 in total

Review 1.  Cysteine cathepsins: their role in tumor progression and recent trends in the development of imaging probes.

Authors:  Reik Löser; Jens Pietzsch
Journal:  Front Chem       Date:  2015-06-23       Impact factor: 5.221

2.  Cerebrospinal fluid cathepsin B and S.

Authors:  Elin Nilsson; Constantin Bodolea; Torsten Gordh; Anders Larsson
Journal:  Neurol Sci       Date:  2012-03-23       Impact factor: 3.307

3.  RAGE expression in tumor-associated macrophages promotes angiogenesis in glioma.

Authors:  Xuebo Chen; Leying Zhang; Ian Y Zhang; Junling Liang; Huaqing Wang; Mao Ouyang; Shihua Wu; Anna Carolina Carvalho da Fonseca; Lihong Weng; Yasuhiko Yamamoto; Hiroshi Yamamoto; Rama Natarajan; Behnam Badie
Journal:  Cancer Res       Date:  2014-10-17       Impact factor: 12.701

4.  Cathepsin S silencing induces apoptosis of human hepatocellular carcinoma cells.

Authors:  Xuedi Wang; Li Xiong; Guotang Yu; Dongdong Li; Tao Peng; Daqing Luo; Jing Xu
Journal:  Am J Transl Res       Date:  2015-01-19       Impact factor: 4.060

5.  Post-translational regulation of cathepsin B, but not of other cysteine cathepsins, contributes to increased glioblastoma cell invasiveness in vitro.

Authors:  Boris Gole; María Beatriz Durán Alonso; Vincenc Dolenc; Tamara Lah
Journal:  Pathol Oncol Res       Date:  2009-05-13       Impact factor: 3.201

Review 6.  Systematic review of protein biomarkers of invasive behavior in glioblastoma.

Authors:  Eli T Sayegh; Gurvinder Kaur; Orin Bloch; Andrew T Parsa
Journal:  Mol Neurobiol       Date:  2013-11-24       Impact factor: 5.590

7.  Microglia in the degenerating brain are capable of phagocytosis of beads and of apoptotic cells, but do not efficiently remove PrPSc, even upon LPS stimulation.

Authors:  Martina M Hughes; Robert H Field; V Hugh Perry; Carol L Murray; Colm Cunningham
Journal:  Glia       Date:  2010-12       Impact factor: 7.452

8.  Protease-activated drug development.

Authors:  Ki Young Choi; Magdalena Swierczewska; Seulki Lee; Xiaoyuan Chen
Journal:  Theranostics       Date:  2012-02-08       Impact factor: 11.556

9.  The role of Cathepsin S as a marker of prognosis and predictor of chemotherapy benefit in adjuvant CRC: a pilot study.

Authors:  J A Gormley; S M Hegarty; A O'Grady; M R Stevenson; R E Burden; H L Barrett; C J Scott; J A Johnston; R H Wilson; E W Kay; P G Johnston; S A Olwill
Journal:  Br J Cancer       Date:  2011-10-11       Impact factor: 7.640

10.  Cystatin F acts as a mediator of immune suppression in glioblastoma.

Authors:  Emanuela Senjor; Milica Perišić Nanut; Barbara Breznik; Ana Mitrović; Jernej Mlakar; Ana Rotter; Andrej Porčnik; Tamara Lah Turnšek; Janko Kos
Journal:  Cell Oncol (Dordr)       Date:  2021-06-29       Impact factor: 6.730

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.